Kailera Therapeutics
Operator of a biopharmaceutical company intended to deliver differentiated treatment options for obesity and related conditions. The company develops a broad, advanced, and differentiated portfolio of...
Valuation
$0
Share Price
N/A
Total Raised
$1B
Last Round
N/A